COGT
Price
$4.94
Change
-$0.04 (-0.80%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
604.58M
82 days until earnings call
DNTH
Price
$18.33
Change
-$0.42 (-2.24%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
614.58M
Interact to see
Advertisement

COGT vs DNTH

Header iconCOGT vs DNTH Comparison
Open Charts COGT vs DNTHBanner chart's image
Cogent Biosciences
Price$4.94
Change-$0.04 (-0.80%)
Volume$30.17K
Capitalization604.58M
Dianthus Therapeutics
Price$18.33
Change-$0.42 (-2.24%)
Volume$3.85K
Capitalization614.58M
COGT vs DNTH Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. DNTH commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Buy and DNTH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (COGT: $4.98 vs. DNTH: $18.75)
Brand notoriety: COGT and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 152% vs. DNTH: 51%
Market capitalization -- COGT: $604.58M vs. DNTH: $614.58M
COGT [@Biotechnology] is valued at $604.58M. DNTH’s [@Biotechnology] market capitalization is $614.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileDNTH’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • DNTH’s FA Score: 0 green, 5 red.
According to our system of comparison, DNTH is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while DNTH’s TA Score has 3 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 2 bearish.
  • DNTH’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, COGT is a better buy in the short-term than DNTH.

Price Growth

COGT (@Biotechnology) experienced а +2.05% price change this week, while DNTH (@Biotechnology) price change was -0.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

DNTH is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($615M) and COGT($605M) have the same market capitalization . DNTH YTD gains are higher at: -13.991 vs. COGT (-36.154). DNTH has higher annual earnings (EBITDA): -101.45M vs. COGT (-284.04M). DNTH has more cash in the bank: 275M vs. COGT (246M). DNTH has less debt than COGT: DNTH (1.49M) vs COGT (17.1M). DNTH has higher revenues than COGT: DNTH (6.24M) vs COGT (0).
COGTDNTHCOGT / DNTH
Capitalization605M615M98%
EBITDA-284.04M-101.45M280%
Gain YTD-36.154-13.991258%
P/E RatioN/A3.24-
Revenue06.24M-
Total Cash246M275M89%
Total Debt17.1M1.49M1,147%
FUNDAMENTALS RATINGS
COGT vs DNTH: Fundamental Ratings
COGT
DNTH
OUTLOOK RATING
1..100
1958
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
7458
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6379
P/E GROWTH RATING
1..100
10064
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DNTH's Valuation (52) in the null industry is in the same range as COGT (81) in the Miscellaneous industry. This means that DNTH’s stock grew similarly to COGT’s over the last 12 months.

DNTH's Profit vs Risk Rating (58) in the null industry is in the same range as COGT (74) in the Miscellaneous industry. This means that DNTH’s stock grew similarly to COGT’s over the last 12 months.

DNTH's SMR Rating (100) in the null industry is in the same range as COGT (100) in the Miscellaneous industry. This means that DNTH’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (63) in the Miscellaneous industry is in the same range as DNTH (79) in the null industry. This means that COGT’s stock grew similarly to DNTH’s over the last 12 months.

DNTH's P/E Growth Rating (64) in the null industry is somewhat better than the same rating for COGT (100) in the Miscellaneous industry. This means that DNTH’s stock grew somewhat faster than COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTDNTH
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 15 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIORX40.64N/A
N/A
Victory Pioneer R
PCCGX10.98N/A
N/A
Victory Pioneer Mid Cap Value C
GSAEX23.99N/A
N/A
Goldman Sachs China Equity Inv
LAVVX15.70N/A
N/A
Lord Abbett Fundamental Equity R6
PMILX10.66N/A
N/A
Putnam Multi-Asset Income R5

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-6.21%
SPHDF - COGT
63%
Loosely correlated
N/A
IDYA - COGT
53%
Loosely correlated
-2.45%
XNCR - COGT
52%
Loosely correlated
-7.62%
ETNB - COGT
52%
Loosely correlated
+6.42%
RCKT - COGT
51%
Loosely correlated
-3.80%
More